F. Tas Et Al. , "A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer," INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.13, no.2, pp.156-160, 2008
Tas, F. Et Al. 2008. A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.13, no.2 , 156-160.
Tas, F., Guney, N., Derin, D., Aydiner, A., & Topuz, E., (2008). A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.13, no.2, 156-160.
Tas, Faruk Et Al. "A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer," INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.13, no.2, 156-160, 2008
Tas, Faruk Et Al. "A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer." INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.13, no.2, pp.156-160, 2008
Tas, F. Et Al. (2008) . "A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer." INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.13, no.2, pp.156-160.
@article{article, author={Faruk TAŞ Et Al. }, title={A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer}, journal={INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY}, year=2008, pages={156-160} }